1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Left Ventricular Systolic Dysfunction: new trials by email Literature Review of Left Ventricular Systolic Dysfunction trials Research Report on Left Ventricular Systolic Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) Vericiguat tablet, Vericiguat suspension, Placebo tablet - Heart Failure, Left Ventricular Systolic Dysfunction | Phase 2 / Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 342 | 2023-05-31 | 2026-11-13 |
| COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure Omecamtiv Mecarbil Matrix F1 Formulation, Omecamtiv Mecarbil Matrix F2 Formulation, Placebo - Modified Release Oral Formulation, Left Ventricular Systolic Dysfunction | Phase 2 | Completed | Cytokinetics | 544 | 2013-02-26 | 2021-08-12 |
Ventricular Dysfunction, Left (2) · Heart Failure (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Ventricular Dysfunction (2)
omecamtiv mecarbil (1) · vericiguat (1)
Cytokinetics (1) · Merck Sharp & Dohme LLC (1)
Belgium (2) · Canada (2) · Germany (2) · Hungary (2) · Italy (2) · Netherlands (2) · Poland (2) · United Kingdom (2) · United States (2) · Australia (1) · Brazil (1) · Bulgaria (1) · Colombia (1) · Croatia (1) · Czechia (1)